- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Vitamin D supplements in Prediabetes patients reduce type 2 diabetes risk, says study
USA: Vitamin D supplementation in patients with prediabetes significantly reduces the risk of type 2 diabetes (T2D), suggests a recent study published in the Journal of Clinical Endocrinology & Metabolism
The effect of vitamin D supplementation on T2D risk remains controversial. Most randomized controlled trials (RCTs) have been small or have reported low doses of vitamin D.
Mahmoud Barbarawi, Department of Internal Medicine, Hurley Medical Center/Michigan State University, Flint, MI, USA, and colleagues conducted a meta-analysis of RCTs testing vitamin D supplementation in the prevention of T2D.
The researchers performed a database search of PubMed/MEDLINE, EMBASE, and the Cochrane Library from inception through September 15, 2019. RCTs that reported the effect of vitamin D supplementation for at least 1 year on T2D prevention, were included.
Two independent reviewers extracted the data. The risk ratios (RRs) and 95% confidence intervals (CIs) were reported. The primary outcome of the meta-analysis was the incidence of T2D.
A total of nine RCTs with 43 559 participants, were included. The mean age (standard deviation) was 63.5 (6.7) years.
Read Also: Foods rich in vitamin C and carotenoids may lower risk of diabetes: Study
Key findings of the study include:
- The RR for vitamin D compared with placebo was 0.96.
- In trials testing moderate to high doses of supplementation (≥1000 IU/day), all conducted among participants with prediabetes, the RR for vitamin D compared with placebo was 0.88.
- The trials testing lower doses, which were conducted in general population samples, showed no risk reduction (RR, 1.02).
"In patients with prediabetes, vitamin D supplementation at moderate to high doses (≥1000 IU/day), significantly reduced the incidence risk of T2DM, compared with placebo," concluded the authors.
Read Also: Vitamin D protein impacts pancreatic function and development of type 1 diabetes
The study, "Effect of Vitamin D Supplementation on the Incidence of Diabetes Mellitus," is published in the Journal of Clinical Endocrinology & Metabolism.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751